| High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation L Gilis, S Morisset, G Billaud, S Ducastelle-Leprêtre, H Labussière-Wallet, ... Bone marrow transplantation 49 (5), 664-670, 2014 | 150 | 2014 |
| Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009 MC Nicolle, T Bénet, A Thiebaut, AL Bienvenu, N Voirin, A Duclos, ... haematologica 96 (11), 1685, 2011 | 91 | 2011 |
| Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation M Michallet, P Dreger, L Sutton, R Brand, S Richards, M van Os, M Sobh, ... Blood, The Journal of the American Society of Hematology 117 (5), 1516-1521, 2011 | 80 | 2011 |
| Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party M Sobh, M Michallet, G Gahrton, S Iacobelli, A van Biezen, S Schönland, ... Leukemia 30 (10), 2047-2054, 2016 | 79 | 2016 |
| Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic … P Dreger, M Michallet, P Bosman, S Dietrich, M Sobh, A Boumendil, ... Bone marrow transplantation 54 (1), 44-52, 2019 | 71 | 2019 |
| High response rate and improved graft-versus-host disease following bortezomib as salvage therapy after reduced intensity conditioning allogeneic stem cell transplantation for … J El-Cheikh, M Michallet, A Nagler, H De Lavallade, FE Nicolini, ... Haematologica 93 (3), 455-458, 2008 | 70 | 2008 |
| Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole M Michallet, M Sobh, S Morisset, S Kraghel, FE Nicolini, X Thomas, ... Medical Mycology 49 (7), 681-687, 2011 | 58 | 2011 |
| The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry M Michallet, M Sobh, D Milligan, S Morisset, D Niederwieser, V Koza, ... Leukemia 24 (10), 1725-1731, 2010 | 53 | 2010 |
| Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients K Laribi, A Baugier de Materre, M Sobh, L Cerroni, CG Valentini, T Aoki, ... Blood Advances 4 (19), 4838-4848, 2020 | 51 | 2020 |
| Invasive aspergillosis: an important risk factor on the short-and long-term survival of acute myeloid leukemia (AML) patients M Michallet, T Bénet, M Sobh, S Kraghel, M El Hamri, G Cannas, ... European journal of clinical microbiology & infectious diseases 31, 991-997, 2012 | 50 | 2012 |
| Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study M Heiblig, D Rea, ML Chrétien, A Charbonnier, P Rousselot, V Coiteux, ... Experimental hematology 67, 41-48, 2018 | 45 | 2018 |
| A matched case–control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication A Conrad, M Le Maréchal, D Dupont, S Ducastelle-Leprêtre, M Balsat, ... Clinical Microbiology and Infection 22 (7), 636-641, 2016 | 43 | 2016 |
| Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia … M Michallet, G Socié, M Mohty, M Sobh, JO Bay, S Morisset, ... Experimental Hematology 41 (2), 127-133, 2013 | 41 | 2013 |
| HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns A Quintela, V Escuret, S Roux, P Bonnafous, L Gilis, F Barraco, ... Journal of Infection 72 (2), 214-222, 2016 | 33 | 2016 |
| Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens M Detrait, V Dubois, M Sobh, S Morisset, N Tedone, H Labussière, L Gillis, ... Experimental Hematology 40 (10), 792-799, 2012 | 32 | 2012 |
| Heavy+ light chain monitoring correlates with clinical outcome in multiple myeloma patients M Michallet, C Chapuis-Cellier, T Dejoie, C Lombard, H Caillon, M Sobh, ... Leukemia 32 (2), 376-382, 2018 | 31 | 2018 |
| Subcutaneous omacetaxine mepesuccinate in patients with chronic myeloid leukemia in tyrosine kinase inhibitor-resistant patients: Review and perspectives M Heiblig, M Sobh, FE Nicolini Leukemia Research 38 (10), 1145-1153, 2014 | 30 | 2014 |
| Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry HL Wallet, M Sobh, S Morisset, M Robin, N Fegueux, S Fürst, M Mohty, ... Experimental hematology 41 (11), 924-933, 2013 | 30 | 2013 |
| Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study M Michallet, M Sobh, F Garban, CE Bulabois, I Yakoub-Agha, V Coiteux, ... Leukemia & Lymphoma 59 (2), 372-380, 2018 | 27 | 2018 |
| Cardio-vascular events occurring on ponatinib in chronic phase chronic myeloid leukemia patients, preliminary analysis of a multicenter cohort FE Nicolini, MC Gagnieu, M Heiblig, E Blond, L Legros, Y Guillermin, ... Blood 122 (21), 4020, 2013 | 24 | 2013 |
